Evidence map›Paper›PMID 32787922›Full record

ArticleActa neuropathologica communications2020

Prominent microglial inclusions in transgenic mouse models of α-synucleinopathy that are distinct from neuronal lesions.

Gaye Tanriöver, Mehtap Bacioglu, Manuel Schweighauser, Jasmin Mahler, Bettina M Wegenast-Braun, Angelos Skodras, Ulrike Obermüller, Melanie Barth, Deborah Kronenberg-Versteeg, K Peter R Nilsson and 4 more

Open access · goldAbstract read
In one paragraph

Article in Acta neuropathologica communications, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Autophagy · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. The Interplay between α-Synuclein and Microglia in α-Synucleinopathies.International journal of molecular sciences · 2023
    Review
  12. Therapeutic functions of astrocytes to treat α-synuclein pathology in Parkinson's disease.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  13. Signatures of glial activity can be detected in the CSF proteome.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 4 countries.

Gaye TanriöverGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany. gaye.tanrioever@dzne.de.
Mehtap BaciogluGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Manuel SchweighauserGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Jasmin MahlerGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Bettina M Wegenast-BraunGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Angelos SkodrasGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Ulrike ObermüllerGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Melanie BarthGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Deborah Kronenberg-VersteegGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
K Peter R NilssonDepartment of Physics, Chemistry and Biology IFM, Linköping University, Linköping, Sweden.
Derya R ShimshekNovartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
Philipp J KahleGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Yvonne S EiseleGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.
Mathias JuckerGerman Center for Neurodegenerative Diseases (DZNE), Tübingen, Germany.ORCID 0000-0001-9045-1072
German Center for Neurodegenerative Diseases · DELinköping University · SENovartis (Switzerland) · CHUniversity of Pittsburgh · US

Funding

Advancing Our Understanding of Oligomer Toxicity in Age-Related Amyloid DisordersR00AG050764 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI EISELE, YVONNE SIMONE · 2019 to 2021
$747k
NIA NIH HHS R00 AG050764
6 · The paper itself

Abstract

Alpha-synucleinopathies are a group of progressive neurodegenerative disorders, characterized by intracellular deposits of aggregated α-synuclein (αS). The clinical heterogeneity of these diseases is thought to be attributed to conformers (or strains) of αS but the contribution of inclusions in various cell types is unclear. The aim of the present work was to study αS conformers among different transgenic (TG) mouse models of α-synucleinopathies. To this end, four different TG mouse models were studied (Prnp-h[A53T]αS; Thy1-h[A53T]αS; Thy1-h[A30P]αS; Thy1-mαS) that overexpress human or murine αS and differed in their age-of-symptom onset and subsequent disease progression. Postmortem analysis of end-stage brains revealed robust neuronal αS pathology as evidenced by accumulation of αS serine 129 (p-αS) phosphorylation in the brainstem of all four TG mouse lines. Overall appearance of the pathology was similar and only modest differences were observed among additionally affected brain regions. To study αS conformers in these mice, we used pentameric formyl thiophene acetic acid (pFTAA), a fluorescent dye with amyloid conformation-dependent spectral properties. Unexpectedly, besides the neuronal αS pathology, we also found abundant pFTAA-positive inclusions in microglia of all four TG mouse lines. These microglial inclusions were also positive for Thioflavin S and showed immunoreactivity with antibodies recognizing the N-terminus of αS, but were largely p-αS-negative. In all four lines, spectral pFTAA analysis revealed conformational differences between microglia and neuronal inclusions but not among the different mouse models. Concomitant with neuronal lesions, microglial inclusions were already present at presymptomatic stages and could also be induced by seeded αS aggregation. Although nature and significance of microglial inclusions for human α-synucleinopathies remain to be clarified, the previously overlooked abundance of microglial inclusions in TG mouse models of α-synucleinopathy bears importance for mechanistic and preclinical-translational studies.

Indexed as

alpha-SynucleinAnimalsDisease Models, AnimalHumansInclusion BodiesMiceMice, TransgenicMicrogliaNeuronsProtein Aggregation, PathologicalProtein ConformationSynucleinopathiesalpha-SynucleinAmyloidConformationInclusionMicrogliaParkinson’s diseasePrion-likeSynuclein

Identifiers

PMID32787922
PMCPMC7425556
OpenAlexW3048854885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.